Emerging Drug Delivery Technologies for Chronic Diseases
American Journal of Pharmaceutics · 31.08.2020 · 1 (4) · 29-43
DOI: 10.71465/ajph1883 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 31.08.2020. Verfasst von Dr. Ali Shahid. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic diseases such as diabetes, cardiovascular disorders, and cancer present significant challenges to healthcare systems worldwide. The management of these diseases often requires long-term medication, leading to the need for advanced drug delivery systems (DDS) that offer controlled release, enhanced bioavailability, and reduced side effects. Emerging drug delivery technologies have focused on improving the efficacy and patient compliance in the treatment of chronic diseases. This paper discusses the various advanced drug delivery technologies, including nanocarriers, liposomes, smart polymers, and targeted delivery systems. It also explores their potential applications, challenges, and future directions in the treatment of chronic conditions.
Zitieren
APA
Shahid, D. A. (2020). Emerging Drug Delivery Technologies for Chronic Diseases. American Journal of Pharmaceutics, 1(4), 29-43. https://doi.org/10.71465/ajph1883
Vancouver
Shahid DA. Emerging Drug Delivery Technologies for Chronic Diseases. American Journal of Pharmaceutics. 2020;1(4):29-43. doi:10.71465/ajph1883
BibTeX
@article{Shahid2020,
author = {Shahid, Dr. Ali},
title = {Emerging Drug Delivery Technologies for Chronic Diseases},
journal = {American Journal of Pharmaceutics},
year = {2020},
volume = {1},
number = {4},
pages = {29--43},
doi = {10.71465/ajph1883}
}
EUVIMED